Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

BUY
$59.06 - $75.72 $11.3 Million - $14.5 Million
191,000 Added 63.67%
491,000 $36.3 Million
Q2 2023

Aug 10, 2023

BUY
$62.68 - $95.05 $18.8 Million - $28.5 Million
300,000 New
300,000 $28.2 Million
Q1 2022

May 13, 2022

SELL
$57.56 - $82.54 $889,071 - $1.27 Million
-15,446 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$90.37 - $122.49 $1.4 Million - $1.89 Million
15,446 New
15,446 $1.4 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Employees Retirement System Of Texas Portfolio

Follow Employees Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.